HRT options for women with fibroids

Patient Care

Volumn 34, Issue 13, 2000, Pages 34-54

  Clark, Brian M ^a   Johnson, Julia V ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24644434012     PISSN: 0031305X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Clark BM, Johnson JV. Effects of postmenopausal hormone replacement therapy on uterine leiomyoma growth measured by ultrasound. Poster presented at: Annual Meeting of the Society for Gynecologic Investigation: March 11, 1999; Atlanta, Ga.
2. Sener AB, Seckin NC, Ozmen S, et al. The effects of postmenopausal HRT on uterine fibroids in postmenopausal women. Fertil Steril. 1996;65:354-357.
3. Goodwin SC, Vedantham S, McLucas B, et al. Preliminary experience with uterine artery embolization for uterine fibroids. J Vasc Interv Radiol. 1997;8:517-526.
4. Kresch AJ, Olive DL. Laparoscopic cryomyolysis. Presented at: Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; May 17, 1999; Philadelphia. Pa.
5. Cravello L, Famarier J, Roger V, et al. Hysteroscopic myomectomy: functional results with an average follow-up of 6 years. J Gynecol Obstet Biol Reprod (Paris). 1998;27:593-597.
6. de Aloysio D, Altieri P, Penacchioni P, et al. Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of hormone replacement therapy. Maturitas. 1998;29:261-264.
7. Istre O. Transcervical resection of endometrium and fibroids: The outcome of 412 operations performed over 5 years. Acta Obstet Gynecol Scand. 1996;75:567-574.
8. Tulandi T, Al-took S. Endoscopic myomectomy. Laparoscopy and hysteroscopy. Obstet Gynecol Clin North Am. 1999;26:135-148.
9. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med. 1997;336:1769-1775.
10. Gregoriou O, Vitoratos N, Papadias C, et al. Effect of tibolone on postmenopausal women with myomas. Maturitas. 1997;27:187-191.
11. Delmas PD, Bjarnason NH, Mitlak BH, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med. 1997;337:1641-1647.
12. Cummings SR, Eckert S, Keueger KA, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women. Results from the MORE randomized trial. JAMA 1999;281:2189-2197.
13. Porter KB, Tsibris JCM, Porter G, et al. The effects of the selective estrogen receptor modulator LY353381 (SERM) and tamoxifen (Tam) on abdominal leiomyoma (L). Growth in the guinea-pig model, as determined by ultrasound. Poster presented at: Annual meeting of the Society for Gynecologic Investigation; March 12,1999; Atlanta, Ga.
14. Farish E, Barnes JF, Fletcher CD, et al. Effects of tibolone on serum lipoprotein and apolipoprotein levels compared with a cyclical estrogen/progestogen regimen. Menopause. 1999;6:98-104.
15. Albertazzi P, Di Micco R, Zanardi E. Tibolone: a review. Maturitas. 1998;30:295-305.
16. Hammar M, Christau S, Nathorst-Boos J, et al. A double-blind, randomized trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. Br J Obstet Gynaecol. 1998;105:904-911.